Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Literature
1.
Niscola P, Scaramucci L, Perrotti A, Fratoni S, Piccioni D, Tendas A, Cupelli L, Dentamaro T, Del Poeta G, de Fabritiis P (2008) Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report. Ann Hematol 87:237–238 doi:10.​1007/​s00277-007-0370-y PubMedCrossRef
2.
Solal-Celigny P, Vazeux R, Vroclans M, Amar M, Herrera A, Bernard JF, Boivin P (1984) Positive Coombs test in acute leukaemia. Br J Haematol 57:563–569PubMed
Metadata
Title
B-lymphoblastic leukaemia presenting as autoimmune haemolytic anaemia
Author
Dries Deeren
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 5/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-008-0620-7

Other articles of this Issue 5/2009

Annals of Hematology 5/2009 Go to the issue

Original Article

The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma

Letter to the Editor

A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp

Review Article

Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma

Original Article

Primary localized stages I and II non-Hodgkin’s lymphoma of the nasopharynx: a retrospective 17-year single institutional experience

Original Article

6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII

Original Article

Sheehan’s syndrome as a rare cause of anaemia secondary to hypopituitarism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits